Technology
Health
Medical

Bellerophon Therapeutics

$0.715
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Pre-Market
$0.00 (0.00%) Pre-Market

Why Robinhood?

You can buy or sell BLPH and other stocks, options, ETFs, and crypto commission-free!

About

Bellerophon Therapeutics, Inc. Common Stock, also called Bellerophon Therapeutics, is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Read More The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.

Employees
17
Headquarters
Warren, New Jersey
Founded
2009
Market Cap
41.96M
Price-Earnings Ratio
55.00
Dividend Yield
0.00
Average Volume
490.83K
High Today
$0.7198
Low Today
$0.6901
Open Price
$0.6994
Volume
125.89K
52 Week High
$3.30
52 Week Low
$0.47

Collections

Technology
Health
Medical
Therapy
2015 IPO
US
North America

News

Simply Wall StMar 8

Did Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Insiders Buy Up More Shares?

It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we’ll take a look at whether insiders have been buying or selling shares in Bellerophon Therapeutics, Inc. (NASDAQ:BLPH). Do Insider Transactions Matter? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries requi...

561

Earnings

-$0.44
-$0.31
-$0.17
-$0.04
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.13 per share
Actual
-$0.08 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.